This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Connective Tissue Diseases  • Dermatologic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Several drugs have been reported to induce subacute cutaneous lupus erythematosus (SCLE), mainly by an enteral route or even a parenteral route, but induction of SCLE by an inhalation route has not previously been described. We report a case of SCLE that was induced by the inhalation of tiotropium bromide, an anticholinergic bronchodilatator drug. Therefore, drugs administered by inhalation should also be considered as a possible cause of drug-induced SCLE.

Report of a Case

A 58-year-old man with chronic obstructive pulmonary disease was treated by inhalation of bronchodilatators. One week after the introduction of tiotropium inhalation, the patient developed asymptomatic skin lesions on his forearms that spread to his trunk within 2 weeks. Six weeks later, the tiotropium treatment was discontinued, and the skin lesions rapidly resolved. Tiotropium treatment was reintroduced 1 month later, and the skin lesions recurred. The patient’s medical history was negative for Raynaud syndrome, photosensitivity, and musculoskeletal symptoms.

Physical examination . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION
Hoang-Chinh Pham, MD; Jean-Hilaire Saurat, MD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medical Dermatology Is Alive and Well
Callen and Robinson
Arch Dermatol 2005;141:825-826.
FULL TEXT